Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy
- Conditions
- Prostate CancerHead and Neck CancerRectum Cancer
- Interventions
- Behavioral: Resistance trainingBehavioral: High-intensity interval training
- Registration Number
- NCT03252821
- Lead Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Brief Summary
The aim of this study is to assess the impact of a high-intensity aerobic training and resistance training on fatigue in prostate, head and neck and rectum cancer patients undergoing radiotherapy.
A three-arm randomized controlled trial will be conducted. Patients will be randomised into either a high-intensity aerobic training group or a resistance training group or a control group. Participants in the training groups will exercised for five to eight weeks. Exercise sessions will be take place 3 days per week under the supervision of an experienced therapist. Subjects will be assessed at baseline and post-intervention. The primary outcome will be fatigue measured using the FACIT-fatigue questionnaire. The secondary outcomes will be: functional capacity, quality of life, executive functions, sleep disturbances, somnolence syndrome, insomnia, depression symptoms.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 78
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Resistance training group Resistance training Muscle strengthening High-intensity aerobic training group High-intensity interval training High intensity interval training
- Primary Outcome Measures
Name Time Method Change in fatigue Assessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer) Fatigue is measured by FACIT-fatigue questionnaire
- Secondary Outcome Measures
Name Time Method Change in functional capacity Assessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer) Functional capacity is measured by 6-minute walk test
Change in quality of life Assessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer) Quality of life is measured by Functional Assessment of Cancer Therapy-General
Change in sleep disturbances Assessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer) Sleep disturbances are measured by Pittsburgh Sleep Quality Index
Change in somnolence syndrome Assessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer) Somnolence syndrome is measured by Epworth Sleepiness Scale
Change in insomnia Assessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer) Insomnia is measured by Insomnia Severity Index
Change in depression symptoms Assessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer) Depression symptoms are measured by Center for Epidemiologic Studies Depression Scale
Change in executive functions Assessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer) Executive functions is measured by the Trail Making Test
Change in dyspnea Assessments at baseline and 5 weeks (rectum cancer) or 7 weeks (head and neck cancer) or 8 weeks (prostate cancer) Dyspnea is measured by Multidimensional Dyspnea Profile
Adherence Weekly through the intervention (during 8 weeks) Percentage of completed sessions
Trial Locations
- Locations (1)
Cliniques universitaires Saint-Luc
🇧🇪Brussels, Belgium